Form 4 for OKYO OKYO Pharma Ltd
Accepted 2026-07-23 16:15:25 ET · period of report 2026-07-21 · accession 0001493152-26-034406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-23 16:15 | 2026-07-21 | OKYO | JACOB GARY S | Chief DEVELOPMENT Off, Dir | A - Grant | $1.40 | +3,500 | 112.4K | +3% | +$4,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-07-21 | A | A | 3,500 | $1.40 | 112,420 | D | — | — |